[HTML][HTML] Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
S Das, SS Kar, S Samanta, J Banerjee, B Giri… - Immunologic …, 2022 - Springer
SARS-CoV-2 is an RNA virus that was identified for the first time in December 2019 in
Wuhan, China. The World Health Organization (WHO) labeled the novel coronavirus …
Wuhan, China. The World Health Organization (WHO) labeled the novel coronavirus …
[HTML][HTML] Rise of the RNA machines–self-amplification in mRNA vaccine design
JDG Comes, GP Pijlman, TAH Hick - Trends in Biotechnology, 2023 - cell.com
Abstract mRNA vaccines have won the race for early COVID-19 vaccine approval, yet
improvements are necessary to retain this leading role in combating infectious diseases. A …
improvements are necessary to retain this leading role in combating infectious diseases. A …
[HTML][HTML] Two green micellar HPLC and mathematically assisted UV spectroscopic methods for the simultaneous determination of molnupiravir and favipiravir as a …
Following the spread of the COVID-19 pandemic crisis, a race was initiated to find a
successful regimen for postinfections. Among those trials, a recent study declared the …
successful regimen for postinfections. Among those trials, a recent study declared the …
An insight overview on COVID-19 mRNA vaccines: advantageous, pharmacology, mechanism of action, and prospective considerations
The worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has urged scientists to present some novel vaccine platforms during this pandemic to …
has urged scientists to present some novel vaccine platforms during this pandemic to …
[HTML][HTML] Nanocarrier vaccine therapeutics for global infectious and chronic diseases
Immunization has the potential to become a viable weapon for the upcoming pandemic and
save millions of lives, while also dramatically lowering the high mortality rate brought on by a …
save millions of lives, while also dramatically lowering the high mortality rate brought on by a …
[HTML][HTML] mRNA vaccines: Why is the biology of retroposition ignored?
T Domazet-Lošo - Genes, 2022 - mdpi.com
The major advantage of mRNA vaccines over more conventional approaches is their
potential for rapid development and large-scale deployment in pandemic situations. In the …
potential for rapid development and large-scale deployment in pandemic situations. In the …
[HTML][HTML] Coronavirus disease (COVID-19) control between drug repurposing and vaccination: a comprehensive overview
Respiratory viruses represent a major public health concern, as they are highly mutated,
resulting in new strains emerging with high pathogenicity. Currently, the world is suffering …
resulting in new strains emerging with high pathogenicity. Currently, the world is suffering …
Effectiveness of mRNA, protein subunit vaccine and viral vectors vaccines against SARS-CoV-2 in people over 18 years old: a systematic review
C Sandoval, D Guerrero, J Muñoz, K Godoy… - Expert Review of …, 2023 - Taylor & Francis
Introduction Vaccines prevent disease and disability; save lives and represent a good
assessment of health interventions. Several systematic reviews on the efficacy and …
assessment of health interventions. Several systematic reviews on the efficacy and …
[HTML][HTML] Vaccines against group B coxsackieviruses and their importance
The group B coxsackieviruses (CVBs) exist in six serotypes (CVB1 to CVB6). Disease
associations have been reported for most serotypes, and multiple serotypes can cause …
associations have been reported for most serotypes, and multiple serotypes can cause …
[HTML][HTML] COVID-19 vaccine: between myth and truth
Since December 2019, a pandemic caused by the newly identified SARS-CoV-2 spread
across the entire globe, causing 364,191,494 confirmed cases of COVID-19 to date. SARS …
across the entire globe, causing 364,191,494 confirmed cases of COVID-19 to date. SARS …